Stokes & Hubbell Capital Management’s Zimmer Biomet ZBH Stock Holding History

Stokes & Hubbell Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$344K	Buy	2,777 +129	+5%	+$14.7K	0.07%	111
2018 Q4	$267K	Buy	2,648 +4	+0.2%	+$450	0.06%	112
2018 Q3	$337K	Buy	2,644 +5	+0.2%	+$595	0.07%	107
2018 Q2	$286K	Buy	2,639 +4	+0.2%	+$435	0.06%	113
2018 Q1	$279K	Buy	2,635 +5	+0.2%	+$581	0.06%	109
2017 Q4	$308K	Buy	2,630 +5	+0.2%	+$565	0.07%	100
2017 Q3	$298K	Buy	+2,625	New	+$303K	0.08%	97

Other funds holding ZBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Stokes & Hubbell Capital Management's ZBH Position: Q1 2019 in Review

Stokes & Hubbell Capital Management increased its Zimmer Biomet (ZBH) stake by 4.9% in Q1 2019, buying an estimated $14.7K and bringing the position to 2,777 shares worth $344K. The position accounts for 0.07% of the portfolio, ranked #111.

Stokes & Hubbell Capital Management first reported a position in ZBH in Q3 2017 and has held it in 7 quarters since. 897 funds tracked by Wall St. Rank hold ZBH as of Q1 2019.

Stokes & Hubbell Capital Management held 2,777 shares of Zimmer Biomet worth $344K as of Q1 2019.
Stokes & Hubbell Capital Management bought 129 Zimmer Biomet shares in Q1 2019, an estimated $14.7K.
Zimmer Biomet made up 0.07% of Stokes & Hubbell Capital Management's portfolio in Q1 2019, its #111 holding.
Stokes & Hubbell Capital Management first reported a position in Zimmer Biomet in Q3 2017 and has held it in 7 quarters since.
897 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2019.

Based on Stokes & Hubbell Capital Management's 13F filing for Q1 2019, filed 24 Apr 2019.